Skip to content
Brand AI

Cocrystal Pharma

Recent events

Recent events tied to this brand in public sources.

Back to profile1 entries

  1. 2020

    Cocrystal Pharma licenses K-State coronavirus research

    Cocrystal Pharma entered a new agreement granting it use of two patented series of protease inhibitors developed through K-State research, for further development of a possible COVID-19 treatment.

    Source